Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of breast carcinoma: Indications and pitfalls with illustrative case examples

Whole-body (18)F-fluorodeoxyglucose positron emission tomography (PET) has been used extensively in the last decade for the primary staging and restaging and to assess response to therapy in these patients. We aim to discuss the diagnostic performance of PET/computed tomography in the initial stagin...

Descripción completa

Detalles Bibliográficos
Autores principales: Abouzied, Moheieldin M., Fathala, Ahmed, AlMuhaideb, Ahmad, Al Qahtani, Mohammed H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745850/
https://www.ncbi.nlm.nih.gov/pubmed/33354172
http://dx.doi.org/10.4103/wjnm.WJNM_88_19
Descripción
Sumario:Whole-body (18)F-fluorodeoxyglucose positron emission tomography (PET) has been used extensively in the last decade for the primary staging and restaging and to assess response to therapy in these patients. We aim to discuss the diagnostic performance of PET/computed tomography in the initial staging of breast carcinoma including the locally advanced disease and to illustrate its role in restaging the disease and in the assessment of response to therapy, particularly after the neoadjuvant chemotherapy. Causes of common pitfalls during image interpretations will be also discussed.

Ejemplares similares